| Name |
|---|
BCAR3 Genebreast cancer anti-estrogen resistance 3 Breast tumors are initially dependent on estrogens for growth and progression and can be inhibited by anti-estrogens such as tamoxifen. However, breast cancers progress to become anti-estrogen resistant. Breast cancer anti-estrogen resistance gene 3 was identified in the search for genes involved in the development of estrogen resistance. The gene encodes a component of intracellular signal transduction that causes estrogen-independent proliferation in human breast cancer cells. The protein contains a putative src homology 2 (SH2) domain, a hall mark of cellular tyrosine kinase signaling molecules, and is partly homologous to the cell division cycle protein CDC48. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012] |
bcar3 Gene SetFrom GeneRIF Biological Term Annotations genes co-occuring with the biological term bcar3 in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. |
BCAR3 Gene SetFrom Pathway Commons Protein-Protein Interactions interacting proteins for BCAR3 from the Pathway Commons Protein-Protein Interactions dataset. |
BCAR3 Gene SetFrom LINCS L1000 CMAP CRISPR Knockout Consensus Signatures genes differentially expressed following the BCAR3 gene perturbation from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. |
BL6398 (BCAR3) Gene Setproteins in the BL6398 (BCAR3) protein complex recovered by IP-MS from the NURSA Protein Complexes dataset. |